MSF welcomes Colombia taking a historic next step towards issuing first-ever compulsory license to increase access to more affordable generic versions of key HIV medicine dolutegravir

endTB clinical trial offers new shortened drug regimens to treat multidrug-resistant TB

Governments must immediately implement latest WHO guidelines to stop children dying from TB

Recent price reductions to WHO-recommended TB tests and treatment should enable more countries to make these vital medical tools available

Governments must now turn words on paper into practice and take the necessary steps to save more lives of people with TB

Cepheid and Danaher have just announced that they are reducing the price of the Xpert MTB/RIF test by 20% in high-TB-burden countries, from US$9.98 to $7.97 per test. This reduction is a significant step, considering the corporations ...

MSF urges ViiV to withdraw problematic purchasing conditions hindering access to HIV prevention drug CAB-LA

MSF warned that access to point-of-care CD4 tests for HIV are under threat because Abbott and Becton Dickinson have decided to stop production

Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many

With affordable generics likely years away, ViiV must make information public on supply of long-acting cabotegravir and global distribution plan to ensure access for people in high HIV burden low- and middle-income countries

MSF called on governments and donors to speed up access to diagnostic tests, and shorter, safer and more effective treatments, for DR-TB.

Findings that prompted WHO to update global DR-TB treatment guidelines now published in the New England Journal of Medicine, show that a much shorter treatment regimen for drug-resistant TB is safer and cured almost 90 percent of ...

MSF calls on ViiV to urgently dismantle barriers to access for long-acting cabotegravir

Next week the Indian government is expected to decide whether it is willing to override patents on two critical tuberculosis (TB) drugs following a court petition filed at the Mumbai High Court by two survivors of TB and activists. MSF ...

MSF calls on governments and donors to step up and speed up TB testing and treatment

The World Health Organization (WHO) released today the 2020 edition of its Global Tuberculosis (TB) Report. The report, which WHO releases annually, features data on disease trends and the response to the epidemic in 198 countries and ...

UNAIDS released today its 2020 Global AIDS Update Report. MSF joins UNAIDS in calling for countries to implement practices to help mitigate the impact of COVID-19 on HIV treatment services.

MSF protested in front of the New York Stock Exchange in New York today, demanding the pharmaceutical corporation Johnson & Johnson make the tuberculosis drug bedaquiline available for all people with drug-resistant TB or no more than ...

Newer medicines for DR-TB are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world.